ESC Premium Access

Heart failure with mid-range ejection fraction: the controversy continues

Event: ESC Congress 2018
Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
Session type: Abstract Sessions
Date: 26 August 2018
Time: 16:45 - 17:45

Congress Session

4 presentations in this session

Predictive value of diastolic dysfunction severity on long-term survival in heart failure patients with mid-range or reduced left ventricular ejection fraction

Speaker: Doctor K. Hu (Wuerzburg, DE)
Thumbnail

Functional behavior of heart failure with mid-range ejection fraction assessed by stress echocardiography and cardiopulmonary exercise test: truly distinctive phenotype o simply mid-way entity?

Speaker: Doctor M. Barletta (Milan, IT)
Thumbnail

Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? - from the ESC-HF Long-Term Registry

Speaker: Doctor A. Kaplon Cieslicka (Warsaw, PL)
Thumbnail

The role of statins in patients with heart failure with preserved, mid-range and reduced ejection fraction; a meta-analysis and systematic review

Speaker: Assistant Professor A. Bielecka-Dabrowa (Lodz, PL)
Thumbnail

4 speakers from this session

Doctor Kai Hu

University Hospital Wuerzburg, Wuerzburg (Germany)
0 follower

Doctor Marta Barletta

IRCCS San Donato Polyclinic, Milan (Italy)
0 follower

Doctor Agnieszka Kaplon Cieslicka

Medical University of Warsaw, Warsaw (Poland)
1 presentation
0 follower

Assistant Professor Agata Magdalena Bielecka-Dabrowa

Medical University of Lodz, Lodz (Poland)
0 follower

This platform is supported by

logo Novo Nordisk